First Line Anti-Tuberculosis Drug Resistance Among Human Immunodeficiency Virus Infected Patients Attending Maryland Comprehensive Care Centre Mathare 4a Nairobi Kenya
Keywords:
Tuberculosis, First Line Drug Resistance, HIV, Kenya, Multi drug resistant tuberculosisAbstract
TB is a major cause of death among people living with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS). Multi drug resistant tuberculosis (MDR-TB) accounts for up to 14 % of all these T.B cases.
References
. Corbett, E.L. Watt, C.J. Walker, W. Maher, D. William, B.G. (2009). The growing burden of tuberculosis in HIV infected patients: global trends and interactions with the HIV epidemic. International Journal of Tuberculosis and Lung Diseases 163: 1009-1021
. Espinal, M. A. Laszlo, A. Simonsen, L. Boulahbal, F. Kim, S. J. Reneiro, A. (2008). Global trends in resistance to anti-tuberculosis drugs. World Health Organization- International Union Against Tuberculosis and Lung Disease. British Medical journal 344:1294-303
. Ferebee S.H. Comstock, G.W. Hammes, L.M. (2008). A controlled trial of community wide Isoniazid prophylaxis in Alaska. Review on Respiratory Diseases 95:935-43
. Gandhi, N.R. Moll, A. Sturn, A. W. Pawinski, R. Govender, T. Lallo, U.(2010). Extensively drug resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in rural area of South Africa, Lancet 368:1575-1584
. Getahun, H. Havlir, D. Granich, R. (2009). Paradigm shift to address drug resistant tuberculosis in people living with HIV needed and needed now. Tropical Medicine and International Health 14: (4) 376-378
. Gillespie, S.H. (2008).
. Hwang SS, Kim HR, Kim HJ, Kim MJ, Lee SM, Yoo CG, Kim YW, Impact of resistance to first line and injectable drugs on treatment out comes in MDR-TB (2011). European Respiratory Journal; 33:581-585
. Kawai, V. Soto, G. Gilman, R. H. and Evans, C.A. (2007).
. Mcshane, H. (2008). Co-infection with HIV and TB: Double trouble. International British Medical Journal 16: (2) 95-100
. Raviglione, M.D. Snider, D.E. Kochi, A. (2010). Global epidemiology of TB: Morbidity and Mortality of Worldwide epidemic. Lancet 273: 220-226
. Sharma S.K. and Mohan A. (2009).
. Squire, S.B. Harries, A.D. Whitty C.J. (2011). Smear negative pulmonary tuberculosis in a DOTS program: Poor outcome in an area of high HIV sero-prevalence. International Journal of Tuberculosis and Lung Diseases 3:521-543
. WHO/GTP, (2010). Surveillance, planning, financing. Geneva, Switzerland.
. World Health Organization, (2008a). Anti-tuberculosis drug resistance in the world 4th global report, world Health Organization, Geneva, Switzerland
. World Health Organization, (2008b). Guidelines for the programmatic management of drug resistant tuberculosis: Emergency update 2008, World health Organization, Geneva, Switzerland.
. World health Organization, (2010). Multi drug and extensively drug resistant TB: Global report on surveillance and response. Report no. WHO/HTM/ TB/2010.3.Geneva: The Organizations; 2010
. World health Organization, (2011). Interim recommendations for the surveillance of drug resistance in tuberculosis
. World Health Organization, International union Against Tuberculosis and Lung disease (2008). Guidelines for surveillance of drug resistance in tuberculosis, World Health Organization Document WHO/TB/96.216: 1-35.
. Cliff, A. and Smith, F. (2007). Epidemiology and control of tuberculosis in Western European cities. International Journal of Tuberculosis and Lung Diseases 7: 751-757.
Downloads
Published
How to Cite
Issue
Section
License
Authors who submit papers with this journal agree to the following terms.
